IL17A and cancer: Cluster II was enriched for IL-17 signaling pathway, TNF signaling pathway, and cytokine–cytokine receptor interaction, and Cluster III was related to MAPK signaling pathway, PI3K-Akt signaling pathway, and MicroRNAs in cancer.